NICOLE WITTEMANN: Open Payments
NPI 1407565229 · LANGHORNE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$883 in 39 payments from 12 companies in 2025. Trend: 2023 $512 · 2024 $737 · 2025 $883
Food & beverage: $883
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $217 |
| E.R. Squibb & Sons, L.L.C. | 4 | $172 |
| Novo Nordisk Inc | 6 | $121 |
| PFIZER INC. | 6 | $97 |
| Novartis Pharmaceuticals Corporation | 5 | $91 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $32 |
| Azurity Pharmaceuticals, Inc. | 1 | $26 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
Products named: REPATHA, Wegovy, ELIQUIS, LEQVIO, CAMZYOS, VERQUVO, FARXIGA, LifeVest.
Industry payments across PA — which companies pay providers there.
